Thrombin mediated cytotoxicity during cerebral ischemia
Thrombin mediated cytotoxicity during cerebral ischemia
批准号:
10327599
负责人:
Patrick D Lyden
金额:
$32.39万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-08-15 至 2021-05-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We propose a novel and exciting hypothesis—based on literature and our own pilot data—that
neuronal injury stimulates astrocyte activation via thrombin and its receptor PAR-1, and the
resulting astrocyte response to injury yields transmissible paracrine protection of neurons.
Together, neurons, astroctyes, endothelial cells, pericytes, and oligodendroglia comprise the
neurovascular unit, or NVU. Data generated from the several aims will yield insights into the
mechanism for the well-documented phenomenon of pre-conditioning; will provide considerable
insights into the mechanisms of differential vulnerability to cerebral injury; and would likely yield
treatment options for stroke patients. To accomplish the aims, we are creating novel conditional
knock-out mice that will provide research tools to the broader research field. The previous
award, R01 NS075930, covered 8/15/2011 to 03/31/2015 and involved 4 aims. All proposed
work has been completed and published or under review. The data from our prior award has
already influenced stroke care significantly, in the form of two funded clinical trials. However, our
prior data could not fully explain the known differences among the elements of the NVU,
specifically, that astrocytes and endothelial cells tolerate ischemia better than neurons. What is
the mechanism of thrombin-mediated pre-conditioning, and can we relate that mechanism to
other forms of pre- and peri-conditioning? Why does the brain contain prothrombin mRNA and
protein and what purpose could be served by thrombin activation in brain? Could we derive
insights about the response of the brain to injury, and specifically explore the cell-subtype
interactions during injury among astrocytes, neurons, pericytes, oligodendroglia, and endothelial
cells? To answer these questions, and to address the central hypothesis of the present award
application, we added significant new models to our repertoire, and generated pilot data
speaking to the feasibility and novelty of the proposed new specific aims.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1089/ther.2019.29070.jjl
发表时间:
2020
期刊:
Therapeutic hypothermia and temperature management
影响因子:
1.2
作者:
[Lundbye,Justin, Badjatia,Neeraj, Polderman,KeesH, Lyden,Patrick]
通讯作者:
Lyden,Patrick
DOI:
10.1161/strokeaha.113.004488
发表时间:
2014-03
期刊:
Stroke
影响因子:
8.3
作者:
[Lyden P, Pereira B, Chen B, Zhao L, Lamb J, Lei IF, Rajput P]
通讯作者:
Rajput P
DOI:
10.1016/j.neuroscience.2014.09.038
发表时间:
2014-12-05
期刊:
NEUROSCIENCE
影响因子:
3.3
作者:
[Rajput, P. S., Lyden, P. D., Chen, B., Lamb, J. A., Pereira, B., Lamb, A., Zhao, L., Lei, I. -F., Bai, J.]
通讯作者:
Bai, J.
Missing outcome data management in acute stroke trials testing iv thrombolytics. Is there risk of bias?
测试静脉溶栓剂的急性卒中试验中缺失结果数据管理。
DOI:
10.1177/2396987320905457
发表时间:
2020
期刊:
European stroke journal
影响因子:
6.1
作者:
[Fernandez-Ferro,Jose, Schwamm,LeeH, Descalzo,MiguelA, MacIsaac,Rachael, Lyden,PatrickD, Lees,KennedyR]
通讯作者:
Lees,KennedyR
The NIH SPAN Coordinating Center
-
批准号:10591751
-
项目类别:
-
资助金额:$100.85万
-
财政年份:2023
-
负责人:Patrick D Lyden
-
依托单位:
ZZ-3K3A-301: A multicenter, randomized, placebo-controlled, double-blinded, Phase 3 study to evaluate the efficacy and safety of 3K3A-APC (RHAPSODY-2)
-
批准号:10305528
-
项目类别:
-
资助金额:$398.01万
-
财政年份:2022
-
负责人:Patrick D Lyden
-
依托单位:
The NIH SPAN Coordinating Center
-
批准号:10074917
-
项目类别:
-
资助金额:$16.7万
-
财政年份:2020
-
负责人:Patrick D Lyden
-
依托单位:
The NIH SPAN Coordinating Center
-
批准号:10224355
-
项目类别:
-
资助金额:$78.29万
-
财政年份:2019
-
负责人:Patrick D Lyden
-
依托单位:
The NIH SPAN Coordinating Center
-
批准号:10339173
-
项目类别:
-
资助金额:$65.58万
-
财政年份:2019
-
负责人:Patrick D Lyden
-
依托单位:
ZZ-3K3A-201: Safety evaluation of 3K3A-APC in ischemic stroke
-
批准号:9095477
-
项目类别:
-
资助金额:$198.86万
-
财政年份:2014
-
负责人:Patrick D Lyden
-
依托单位:
ZZ-3K3A-201: Safety evaluation of 3K3A-APC in ischemic stroke
-
批准号:8760276
-
项目类别:
-
资助金额:$243.98万
-
财政年份:2014
-
负责人:Patrick D Lyden
-
依托单位:
ZZ-3K3A-201: Safety evaluation of 3K3A-APC in ischemic stroke
-
批准号:8880302
-
项目类别:
-
资助金额:$217.67万
-
财政年份:2014
-
负责人:Patrick D Lyden
-
依托单位:
Thrombin mediated cytotoxicity during cerebral ischemia
-
批准号:9927678
-
项目类别:
-
资助金额:$11.02万
-
财政年份:2011
-
负责人:Patrick D Lyden
-
依托单位:
Thrombin Mediated Cytotoxicity during Cerebral Ischemia
-
批准号:8448649
-
项目类别:
-
资助金额:$35.25万
-
财政年份:2011
-
负责人:Patrick D Lyden
-
依托单位:
Thrombin Mediated Cytotoxicity during Cerebral Ischemia
-
批准号:8318076
-
项目类别:
-
资助金额:$36.53万
-
财政年份:2011
-
负责人:Patrick D Lyden
-
依托单位:
Thrombin Mediated Cytotoxicity during Cerebral Ischemia
-
批准号:8250245
-
项目类别:
-
资助金额:$36.53万
-
财政年份:2011
-
负责人:Patrick D Lyden
-
依托单位:
Quantitation of Early Vascular Leakage after Stroke
-
批准号:6961558
-
项目类别:
-
资助金额:$20.04万
-
财政年份:2005
-
负责人:Patrick D Lyden
-
依托单位:
Quantitation of Early Vascular Leakage after Stroke
-
批准号:7140319
-
项目类别:
-
资助金额:$16.3万
-
财政年份:2005
-
负责人:Patrick D Lyden
-
依托单位:
Therapeutic Window for Acute Stroke Therapy
-
批准号:6948413
-
项目类别:
-
资助金额:$6.3万
-
财政年份:2003
-
负责人:Patrick D Lyden
-
依托单位:
Therapeutic Window for Acute Stroke Therapy
-
批准号:7166130
-
项目类别:
-
资助金额:$6.62万
-
财政年份:2003
-
负责人:Patrick D Lyden
-
依托单位:
Hypothermia
-
批准号:6751836
-
项目类别:
-
资助金额:$15.35万
-
财政年份:2003
-
负责人:Patrick D Lyden
-
依托单位:
Therapeutic Window for Acute Stroke Therapy
-
批准号:7247999
-
项目类别:
-
资助金额:$128.85万
-
财政年份:2003
-
负责人:Patrick D Lyden
-
依托单位:
Therapeutic Window for Acute Stroke Therapy (P50)
-
批准号:7629859
-
项目类别:
-
资助金额:$16.88万
-
财政年份:2003
-
负责人:Patrick D Lyden
-
依托单位:
Therapeutic Window for Acute Stroke Therapy
-
批准号:6749550
-
项目类别:
-
资助金额:$119.42万
-
财政年份:2003
-
负责人:Patrick D Lyden
-
依托单位:
国内基金
海外基金
登录
查看更多内容
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
-
批准号:82372275
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘耀宝
-
依托单位:
基于NLRP3/IL-1β信号探讨α7nAChR介导巨噬细胞—心肌细胞互作在Aβ诱导房颤心房重构中的作用及机制研究
-
批准号:82300356
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:赵继凯
-
依托单位:
Tom1L1在胞内体蛋白分选机制中功能的研究
-
批准号:31171289
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2011
-
负责人:刘宁生
-
依托单位:
溶酶体依赖性TRAF2降解的机制
-
批准号:30971501
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2009
-
负责人:李联运
-
依托单位: